LYCOS RETRIEVER 
Organon: Products
built 622 days ago
Two Organon issues are special planning tools. The June Worldwide Manufactured Fiber Survey contains production and producing capacity by country — by generic fiber and geographic area. The September End Use Survey reports on fiber quantities — manufactured and natural — used in the production over 70 end use items, e.g., carpet and rugs, curtains, sweaters, filtration . . . .
Source:
Prior to joining Organon, from 1982 to 1986 Mr. Novinski held several positions in product management with Wyeth-Ayerst International. In 1986, he was appointed Product Marketing Director, Female Healthcare. In 1988, he was appointed Group Marketing Director, Pharmaceuticals. From 1990-1992, he was the Assistant Vice President in Market Planning for Pharmaceuticals and was responsible for the international marketing of products.
Source:
It ... attests to the promising drugs that Organon is now steering through the final Phase III stage of clinical trials. Schering says that the acquisition will fill a gap in its late stage pipeline and provide immediate access to central nervous system and women's health care products.
Source:
*Organon is voluntarily withdrawing Raplon following reports indicating that the drug may be associated with bronchospasm. Product labeling did note the occurrence of bronchospasm in a small percentage of patients during clinical trials; ... several serious adverse events, including bronchospasm and unexplained fatalities, were reported during postmarketing surveillance. Source: FDA - Organon correspondence to physicians - 03/27/01.
Source:
MORE ABOUT
Products